|
US20020192198A1
(en)
*
|
1998-04-21 |
2002-12-19 |
Elia James P. |
Method for growing human organs and suborgans
|
|
US20030157074A1
(en)
*
|
1994-11-16 |
2003-08-21 |
Mitrani Eduardo N. |
Vitro micro-organs, and uses related thereto
|
|
US8075880B2
(en)
|
1999-01-11 |
2011-12-13 |
Steward St. Elizabeth's Medical Center Of Boston, Inc. |
Compositions and methods for regulating angiogenesis
|
|
US5980887A
(en)
*
|
1996-11-08 |
1999-11-09 |
St. Elizabeth's Medical Center Of Boston |
Methods for enhancing angiogenesis with endothelial progenitor cells
|
|
US6486133B1
(en)
|
1997-03-07 |
2002-11-26 |
The Wistar Institute Of Anatomy And Biology |
Methods for inducing localized vascular development and enhancing the repair of a wound in the mammamian dermis
|
|
EP1019082B2
(en)
*
|
1997-10-02 |
2008-06-04 |
Max-Planck-Gesellschaft Zur Förderung Der Wissenschaften E.V. |
Use of a colony stimulating factor (csf) for enhancing collateral growth of collateral arteries and/or other arteries from preexisting arteriolar connections
|
|
US6749617B1
(en)
*
|
1997-11-04 |
2004-06-15 |
Scimed Life Systems, Inc. |
Catheter and implants for the delivery of therapeutic agents to tissues
|
|
US7687057B2
(en)
*
|
1998-01-09 |
2010-03-30 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
In vitro micro-organs, and uses related thereto
|
|
JP2002500879A
(ja)
*
|
1998-01-23 |
2002-01-15 |
イムクローン システムズ インコーポレーテッド |
幹細胞の精製ポピュレーション
|
|
AU766238B2
(en)
*
|
1998-03-09 |
2003-10-09 |
Caritas St. Elizabeth's Medical Center Of Boston, Inc. |
Compositions and methods for modulating vascularization
|
|
US6676937B1
(en)
*
|
1998-03-09 |
2004-01-13 |
Caritas St. Elizabeth's Medical Center Of Boston Inc. |
Compositions and methods for modulating vascularization
|
|
US20040228834A1
(en)
*
|
1998-03-09 |
2004-11-18 |
Jeffrey Isner |
Compositions and methods for modulating vascularization
|
|
CA2266805C
(en)
|
1998-03-27 |
2015-04-28 |
An-Go-Gen Inc. |
Cell-based gene therapy in the treatment of pulmonary disorders
|
|
US6482406B1
(en)
|
1999-03-26 |
2002-11-19 |
Duncan J. Stewart |
Cell-based gene therapy for the pulmonary system
|
|
US9585916B2
(en)
|
1999-03-26 |
2017-03-07 |
Northern Therapeutics Inc. |
Cell based therapy for the pulmonary system
|
|
US8197430B1
(en)
|
1998-05-22 |
2012-06-12 |
Biopheresis Technologies, Inc. |
Method and system to remove cytokine inhibitor in patients
|
|
US6620382B1
(en)
*
|
1998-05-22 |
2003-09-16 |
Biopheresis Technologies, Llc. |
Method and compositions for treatment of cancers
|
|
CA2336813A1
(en)
|
1998-07-10 |
2000-01-20 |
Victor J. Dzau |
Methods for implanting cells
|
|
US6677300B1
(en)
*
|
1998-09-09 |
2004-01-13 |
Scios, Inc. |
Treatment of microvascular angiopathies
|
|
US7030083B2
(en)
*
|
1998-09-09 |
2006-04-18 |
University Of Washington |
Treatment of eclampsia and preeclampsia
|
|
US6958147B1
(en)
|
1998-10-26 |
2005-10-25 |
Licentia Ltd |
Use of VEGF-C to prevent restenosis
|
|
EP1568375A1
(en)
*
|
1998-10-26 |
2005-08-31 |
Ludwig Institute For Cancer Research |
Use of VEGF-C or VEGF-D gene or protein to prevent restenosis
|
|
EP1126870B1
(en)
*
|
1998-10-26 |
2004-09-08 |
Ludwig Institute For Cancer Research |
Use of vegf-c or vegf-d gene or protein to prevent restenosis
|
|
DE19850986A1
(de)
*
|
1998-11-05 |
2000-05-25 |
Aventis Pharma Gmbh |
Die gentechnische Prägung von Zellen und ihre Verwendung zur Prophylaxe und Therapie von Erkrankungen
|
|
JP2002537761A
(ja)
*
|
1998-11-24 |
2002-11-12 |
リージェンツ オブ ザ ユニバーシティ オブ ミネソタ |
トランスジェニック循環内皮細胞
|
|
US20040131601A1
(en)
*
|
2000-03-30 |
2004-07-08 |
Foundry Networks, Inc., A Delaward Corporation |
Injection of bone marrow-derived cells and medium for angiogenesis
|
|
US6348050B1
(en)
*
|
1999-04-30 |
2002-02-19 |
Medtronic, Inc. |
Infusion systems for creating microenvironments in a living body
|
|
US20030152562A1
(en)
*
|
2001-10-23 |
2003-08-14 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Vitro micro-organs, and uses related thereto
|
|
US8062675B2
(en)
|
1999-07-07 |
2011-11-22 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
US20050158289A1
(en)
*
|
1999-07-07 |
2005-07-21 |
Simmons Paul J. |
Mesenchymal precursor cell and use thereof in the repair of bone defects and fractures in mammals
|
|
AU2003901668A0
(en)
|
2003-03-28 |
2003-05-01 |
Medvet Science Pty. Ltd. |
Non-haemopoietic precursor cells
|
|
AUPQ147799A0
(en)
*
|
1999-07-07 |
1999-07-29 |
Medvet Science Pty. Ltd. |
Mesenchymal precursor cell
|
|
US7670628B2
(en)
*
|
1999-07-07 |
2010-03-02 |
Angioblast Systems, Inc. |
Mesenchymal precursor cell
|
|
AU6920800A
(en)
*
|
1999-08-19 |
2001-03-13 |
Stem Cell Pharmaceuticals, Inc. |
Tgf-alpha polypeptides, functional fragments and methods of use therefor
|
|
US20020193301A1
(en)
|
1999-08-19 |
2002-12-19 |
Stem Cell Pharmaceuticals, Inc. |
TGF-alpha polypeptides, functional fragments and methods of use therefor
|
|
DE69936320T2
(de)
*
|
1999-09-23 |
2008-02-21 |
An-Go-Gen Inc., Toronto |
Zellbasierte gentherapie für das lungensystem
|
|
PT1142590E
(pt)
*
|
1999-10-29 |
2008-10-27 |
Anges Mg Inc |
Terapêutica génica para doença isquémica diabética
|
|
US6379708B1
(en)
*
|
1999-11-20 |
2002-04-30 |
Cytologic, Llc |
Method for enhancing immune responses in mammals
|
|
US8088060B2
(en)
*
|
2000-03-15 |
2012-01-03 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US9522217B2
(en)
*
|
2000-03-15 |
2016-12-20 |
Orbusneich Medical, Inc. |
Medical device with coating for capturing genetically-altered cells and methods for using same
|
|
US8460367B2
(en)
*
|
2000-03-15 |
2013-06-11 |
Orbusneich Medical, Inc. |
Progenitor endothelial cell capturing with a drug eluting implantable medical device
|
|
US20030229393A1
(en)
*
|
2001-03-15 |
2003-12-11 |
Kutryk Michael J. B. |
Medical device with coating that promotes cell adherence and differentiation
|
|
CN100506293C
(zh)
|
2000-03-15 |
2009-07-01 |
祥丰医疗有限公司 |
促进内皮细胞粘附的涂层
|
|
US20070055367A1
(en)
*
|
2000-03-15 |
2007-03-08 |
Orbus Medical Technologies, Inc. |
Medical device with coating that promotes endothelial cell adherence and differentiation
|
|
US20030104977A1
(en)
*
|
2000-03-31 |
2003-06-05 |
Ugo Ripamonti |
Methods for inducing angiogenesis using morphogenic proteins and stimulatory factors
|
|
US9694038B2
(en)
*
|
2000-04-06 |
2017-07-04 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US20100303769A1
(en)
*
|
2000-04-06 |
2010-12-02 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US20050277576A1
(en)
*
|
2000-04-06 |
2005-12-15 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US10281478B2
(en)
|
2000-04-06 |
2019-05-07 |
Wayne P. Franco |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US7166280B2
(en)
*
|
2000-04-06 |
2007-01-23 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic heart disease
|
|
US20070111935A1
(en)
*
|
2000-04-06 |
2007-05-17 |
Franco Wayne P |
Combination growth factor therapy and cell therapy for treatment of acute and chronic diseases of the organs
|
|
US6800298B1
(en)
*
|
2000-05-11 |
2004-10-05 |
Clemson University |
Biological lubricant composition and method of applying lubricant composition
|
|
WO2001094420A1
(en)
*
|
2000-06-05 |
2001-12-13 |
The Trustees Of Columbia University In The City Of New York |
Identification and use of human bone marrow-derived endothelial progenitor cells to improve myocardial function after ischemic injury
|
|
EP1303588B1
(en)
*
|
2000-07-26 |
2012-10-24 |
Boston Scientific Limited |
Therapeutic angiogenesis by bone marrow-derived cell transplantation in myocardial ischemic tissue and skeletal muscle ischemic tissue
|
|
DE60142584D1
(de)
*
|
2000-11-08 |
2010-08-26 |
Boston Scient Ltd |
Multilumen katheter und implantate zur verabreichung von therapeutischen substanzen an gewebe
|
|
WO2003019136A2
(en)
*
|
2001-08-06 |
2003-03-06 |
The Regents Of The University Of California |
Methods for inhibiting angiogenesis
|
|
WO2003013570A1
(en)
*
|
2001-08-09 |
2003-02-20 |
Cornell Research Foundation, Inc. |
Platelet-derived growth factor protection of cardiac myocardium
|
|
WO2003018752A2
(en)
*
|
2001-08-23 |
2003-03-06 |
The Wistar Institute Of Anatomy And Biology |
An organotypic intestinal culture and methods of use thereof
|
|
US20030054331A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Stemsource, Inc. |
Preservation of non embryonic cells from non hematopoietic tissues
|
|
US20040031067A1
(en)
*
|
2001-10-11 |
2004-02-12 |
Meenhard Herlyn |
Regulation of human skin healing
|
|
US20040044403A1
(en)
*
|
2001-10-30 |
2004-03-04 |
Joyce Bischoff |
Tissue-engineered vascular structures
|
|
WO2003049626A1
(en)
*
|
2001-11-05 |
2003-06-19 |
Medgenics, Inc. |
Method and apparatus for production of a skin graft and the graft produced thereby
|
|
US8608661B1
(en)
|
2001-11-30 |
2013-12-17 |
Advanced Cardiovascular Systems, Inc. |
Method for intravascular delivery of a treatment agent beyond a blood vessel wall
|
|
US7514075B2
(en)
*
|
2001-12-07 |
2009-04-07 |
Cytori Therapeutics, Inc. |
Systems and methods for separating and concentrating adipose derived stem cells from tissue
|
|
US7651684B2
(en)
|
2001-12-07 |
2010-01-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
|
|
US20050048035A1
(en)
*
|
2001-12-07 |
2005-03-03 |
Fraser John K. |
Methods of using regenerative cells in the treatment of stroke and related diseases and disorders
|
|
AU2002357135C1
(en)
*
|
2001-12-07 |
2009-01-22 |
Macropore Biosurgery, Inc. |
Systems and methods for treating patients with processed lipoaspirate cells
|
|
US7771716B2
(en)
|
2001-12-07 |
2010-08-10 |
Cytori Therapeutics, Inc. |
Methods of using regenerative cells in the treatment of musculoskeletal disorders
|
|
US7585670B2
(en)
*
|
2001-12-07 |
2009-09-08 |
Cytori Therapeutics, Inc. |
Automated methods for isolating and using clinically safe adipose derived regenerative cells
|
|
US20050095228A1
(en)
|
2001-12-07 |
2005-05-05 |
Fraser John K. |
Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
|
|
US8404229B2
(en)
*
|
2001-12-07 |
2013-03-26 |
Cytori Therapeutics, Inc. |
Methods of using adipose derived stem cells to treat acute tubular necrosis
|
|
US9597395B2
(en)
|
2001-12-07 |
2017-03-21 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
US20060204556A1
(en)
*
|
2001-12-07 |
2006-09-14 |
Cytori Therapeutics, Inc. |
Cell-loaded prostheses for regenerative intraluminal applications
|
|
US7595043B2
(en)
*
|
2001-12-07 |
2009-09-29 |
Cytori Therapeutics, Inc. |
Method for processing and using adipose-derived stem cells
|
|
WO2006075986A1
(en)
*
|
2005-01-10 |
2006-07-20 |
Macropore Biosurgery, Inc. |
Devices and methods for monitoring, managing, and servicing medical devices
|
|
US20050008626A1
(en)
*
|
2001-12-07 |
2005-01-13 |
Fraser John K. |
Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
|
|
JP2005518828A
(ja)
*
|
2001-12-20 |
2005-06-30 |
マクロポア インコーポレイテッド |
脂肪組織から抽出したコラーゲンに富む物質を用いた患者を治療するためのシステム及び方法
|
|
DE60235836D1
(de)
*
|
2001-12-21 |
2010-05-12 |
Immunex Corp |
Ahren und verwendung davon
|
|
US20030139333A1
(en)
*
|
2002-01-18 |
2003-07-24 |
Genetix Pharmaceuticals, Inc. |
Methods and compositions for promoting angiogenesis
|
|
US20040009146A1
(en)
*
|
2002-02-26 |
2004-01-15 |
Osvaldo Podhajcer |
Anti-tumor vaccine and method
|
|
US20030199464A1
(en)
*
|
2002-04-23 |
2003-10-23 |
Silviu Itescu |
Regeneration of endogenous myocardial tissue by induction of neovascularization
|
|
US7361368B2
(en)
|
2002-06-28 |
2008-04-22 |
Advanced Cardiovascular Systems, Inc. |
Device and method for combining a treatment agent and a gel
|
|
US20040009158A1
(en)
*
|
2002-07-11 |
2004-01-15 |
Washington University |
Promotion of neovascularization using bone marrow-derived endothelial-progenitor cells
|
|
WO2004007698A1
(en)
*
|
2002-07-12 |
2004-01-22 |
National University Of Singapore |
Hemangioblast progenitor cells
|
|
US20040052771A1
(en)
*
|
2002-07-12 |
2004-03-18 |
Lim Sai Kiang |
Hemangioblast progenitor cells
|
|
EP1534345A4
(en)
*
|
2002-07-12 |
2012-03-21 |
Yissum Res Dev Co |
METHOD AND DEVICE FOR INDUCING BIOLOGICAL PROCESSES WITH MICROORGANISMS
|
|
DE10234192B4
(de)
*
|
2002-07-26 |
2009-11-26 |
Epoplus Gmbh Co.Kg |
Verwendung von Erythropoetin
|
|
US20050271639A1
(en)
*
|
2002-08-22 |
2005-12-08 |
Penn Marc S |
Genetically engineered cells for therapeutic applications
|
|
US20040037811A1
(en)
*
|
2002-08-22 |
2004-02-26 |
The Cleveland Clinic Foundation |
Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
|
|
JP4672370B2
(ja)
*
|
2002-12-05 |
2011-04-20 |
ケース ウエスタン リザーブ ユニバーシティ |
虚血の細胞ベースの治療
|
|
US7470538B2
(en)
*
|
2002-12-05 |
2008-12-30 |
Case Western Reserve University |
Cell-based therapies for ischemia
|
|
US7060684B1
(en)
|
2002-12-16 |
2006-06-13 |
Quijano Rodolfo C |
Device for treating diabetes and methods thereof
|
|
US8940292B2
(en)
|
2003-01-28 |
2015-01-27 |
Wake Forest University Health Sciences |
Enhancement of angiogenesis to grafts using cells engineered to produce growth factors
|
|
US20040197310A1
(en)
*
|
2003-02-12 |
2004-10-07 |
Sanberg Paul R. |
Compositions and methods for using umbilical cord progenitor cells in the treatment of myocardial infarction
|
|
WO2004087736A2
(en)
*
|
2003-03-27 |
2004-10-14 |
The Texase A & M University System |
Uses of vascular endothelial growth factor and type i collagen inducible protein (vcip)
|
|
US8383158B2
(en)
|
2003-04-15 |
2013-02-26 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US8038991B1
(en)
|
2003-04-15 |
2011-10-18 |
Abbott Cardiovascular Systems Inc. |
High-viscosity hyaluronic acid compositions to treat myocardial conditions
|
|
US8821473B2
(en)
|
2003-04-15 |
2014-09-02 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions to treat myocardial conditions
|
|
US20040247575A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Caplice Noel M. |
Smooth muscle progenitor cells
|
|
JP5019511B2
(ja)
*
|
2003-09-17 |
2012-09-05 |
サイトリ セラピューティクス インコーポレイテッド |
抹消血管疾患およびそれに関連する障害の治療において新生細胞を利用する方法
|
|
WO2005033275A2
(en)
*
|
2003-09-29 |
2005-04-14 |
The Regents Of The University Of California |
Methods for altering hematopoietic progenitor cell adhesion, differentiation, and migration
|
|
US20090118817A1
(en)
*
|
2005-06-16 |
2009-05-07 |
Mayo Foundation For Medical Education And Research |
Magnetic Medical Apparatus, Kits, and Methods
|
|
US8465453B2
(en)
*
|
2003-12-03 |
2013-06-18 |
Mayo Foundation For Medical Education And Research |
Kits, apparatus and methods for magnetically coating medical devices with living cells
|
|
DE102004004509B4
(de)
*
|
2004-01-23 |
2010-07-01 |
Epoplus Gmbh Co.Kg |
Einsatz von niedrig dosiertem Erythropoietin zur Stimulation endothelialer Vorläuferzellen sowie zur Organregeneration und Progressionsverlangsamung von Endorganschäden
|
|
JP2007217283A
(ja)
*
|
2004-03-30 |
2007-08-30 |
Niigata Tlo:Kk |
血管新生促進剤および血管新生療法
|
|
WO2005107817A2
(en)
*
|
2004-04-30 |
2005-11-17 |
Orbus Medical Technologies, Inc. |
Medical device with coating for capturing genetically-altered cells and methods of using same
|
|
EP1756267A2
(en)
|
2004-05-14 |
2007-02-28 |
Becton, Dickinson and Company |
Stem cell populations and methods of use
|
|
EP1759536B1
(en)
|
2004-06-01 |
2011-05-18 |
Kwalata Trading Limited |
In vitro techniques for use with stem cells
|
|
CA2574186A1
(en)
*
|
2004-08-13 |
2006-02-23 |
Medtronic, Inc. |
Isolation of endothelial progenitor cell subsets and methods for their use
|
|
CA2581237C
(en)
*
|
2004-09-24 |
2018-11-06 |
Angioblast Systems, Inc. |
Method of enhancing proliferation and/or survival of mesenchymal precursor cells (mpc)
|
|
JP2008515818A
(ja)
*
|
2004-10-07 |
2008-05-15 |
ステム セル セラピューティクス コーポレイション |
妊娠に関連する化合物の投与による多能性幹細胞の増殖の刺激
|
|
EP1827494A4
(en)
*
|
2004-11-18 |
2010-02-17 |
Wayne Franco |
COMBINATION GROWTH THERAPY AND CELL THERAPY FOR THE TREATMENT OF ACUTE AND CHRONIC ORGANIC DISEASES
|
|
US20060110374A1
(en)
*
|
2004-11-24 |
2006-05-25 |
Dudy Czeiger |
Method to accelerate stem cell recruitment and homing
|
|
WO2006060779A2
(en)
*
|
2004-12-03 |
2006-06-08 |
Case Western Reserve University |
Novel methods, compositions and devices for inducing neovascularization
|
|
WO2006111198A1
(en)
*
|
2005-04-18 |
2006-10-26 |
Associazione Foresta Per La Ricerca Nella Riproduzione Umana |
Use of pde-5 inhibitors for endothelial repair of tissues impaired by trauma or disease
|
|
US8828433B2
(en)
*
|
2005-04-19 |
2014-09-09 |
Advanced Cardiovascular Systems, Inc. |
Hydrogel bioscaffoldings and biomedical device coatings
|
|
US20080125745A1
(en)
|
2005-04-19 |
2008-05-29 |
Shubhayu Basu |
Methods and compositions for treating post-cardial infarction damage
|
|
US9539410B2
(en)
|
2005-04-19 |
2017-01-10 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating post-cardial infarction damage
|
|
FR2889200B1
(fr)
*
|
2005-07-27 |
2008-01-04 |
Inst Vaisseaux Et Du Sang Ass |
Systeme marqueur cellulaire/ligand, ou le marqueur est du type eph, materiau cellulaire comprenant ce systeme, procede de preparation et utilisation proangiogenique
|
|
US20070065514A1
(en)
*
|
2005-09-22 |
2007-03-22 |
Howell Mark D |
Method for enhancing immune responses in mammals
|
|
US7652922B2
(en)
*
|
2005-09-30 |
2010-01-26 |
Mosaid Technologies Incorporated |
Multiple independent serial link memory
|
|
US20070100323A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Ludwig Florian N |
Facilitation of endothelialization by in situ surface modification
|
|
US20110076255A1
(en)
|
2005-11-07 |
2011-03-31 |
Pecora Andrew L |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
PT2441461E
(pt)
|
2005-11-07 |
2014-08-26 |
Amorcyte Inc |
Composições e métodos de reparação de lesões vasculares
|
|
US8637005B2
(en)
|
2005-11-07 |
2014-01-28 |
Amorcyte, Inc. |
Compositions and methods of vascular injury repair
|
|
TW200734462A
(en)
|
2006-03-08 |
2007-09-16 |
In Motion Invest Ltd |
Regulating stem cells
|
|
US7732190B2
(en)
|
2006-07-31 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US9242005B1
(en)
*
|
2006-08-21 |
2016-01-26 |
Abbott Cardiovascular Systems Inc. |
Pro-healing agent formulation compositions, methods and treatments
|
|
US20080075690A1
(en)
*
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
|
EP2068897A1
(en)
*
|
2006-10-03 |
2009-06-17 |
Medtronic, Inc. |
Endothelial progenitor cell compositions and neovascularization
|
|
WO2008085229A2
(en)
*
|
2006-11-15 |
2008-07-17 |
Arteriocyte Inc. |
Cell-based therapies for treating liver disease
|
|
US9005672B2
(en)
|
2006-11-17 |
2015-04-14 |
Abbott Cardiovascular Systems Inc. |
Methods of modifying myocardial infarction expansion
|
|
US8741326B2
(en)
|
2006-11-17 |
2014-06-03 |
Abbott Cardiovascular Systems Inc. |
Modified two-component gelation systems, methods of use and methods of manufacture
|
|
US8192760B2
(en)
|
2006-12-04 |
2012-06-05 |
Abbott Cardiovascular Systems Inc. |
Methods and compositions for treating tissue using silk proteins
|
|
FR2909559B1
(fr)
*
|
2006-12-06 |
2012-09-07 |
Inst Vaisseaux Et Du Sang |
Preparations cellulaires pour une utilisation comme agent stimulant la revascularisation
|
|
WO2008077094A2
(en)
*
|
2006-12-19 |
2008-06-26 |
Children's Medical Center Corporation |
Methods for promoting neovascularization
|
|
US8137968B2
(en)
*
|
2007-02-28 |
2012-03-20 |
The Board Of Trustees Of The University Of Illinois |
Selected endothelial progenitor cells and methods for use
|
|
AU2008223817A1
(en)
*
|
2007-03-02 |
2008-09-12 |
National University Of Ireland, Galway |
Osteopontin for the prediction and treatment of cardiovascular diseases
|
|
US7632340B2
(en)
*
|
2007-03-07 |
2009-12-15 |
Hamilton Beach Brands, Inc. |
Air purifier for removing particles or contaminants from air
|
|
ES2520044T3
(es)
|
2007-03-30 |
2014-11-11 |
The Cleveland Clinic Foundation |
SDF-1 para su uso en el tratamiento de trastornos vasculares periféricos isquémicos
|
|
US8491887B2
(en)
*
|
2007-05-18 |
2013-07-23 |
National University Corporation Asahikawa Medical University |
Anticancer therapy by transplanting vascular endothelial progenitor cells
|
|
ES2382022T3
(es)
*
|
2007-06-13 |
2012-06-04 |
Wake Forest University Health Sciences |
Procedimientos de restauración de la función erectil
|
|
US20090053208A1
(en)
*
|
2007-08-20 |
2009-02-26 |
Medtronic Vascular, Inc. |
Methods and Systems for Improving Tissue Perfusion
|
|
WO2009079451A2
(en)
*
|
2007-12-14 |
2009-06-25 |
The Cleveland Clinic Foundation |
Compositions and methods of promoting wound healing
|
|
US11051733B2
(en)
|
2008-01-18 |
2021-07-06 |
Wake Forest University Health Sciences |
Isolating and purifying cells for therapy
|
|
US20090246179A1
(en)
*
|
2008-02-11 |
2009-10-01 |
The Cleveland Clinic Foundation |
Method of treating myocardial injury
|
|
WO2010006219A2
(en)
*
|
2008-07-09 |
2010-01-14 |
Baxter International Inc. |
Use of scaffold comprising fibrin for delivery of stem cells
|
|
WO2010021993A1
(en)
|
2008-08-19 |
2010-02-25 |
Cytori Therapeutics, Inc. |
Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
|
|
CN102245189B
(zh)
*
|
2008-12-03 |
2015-06-17 |
阿莫塞特公司 |
改善梗死区灌注的组合物以及血管损伤修复方法
|
|
EP2418272A4
(en)
|
2009-04-07 |
2013-02-27 |
Nat University Corp Asahikawa Medical University |
NOVEL REVASCULARIZATION CELLS DERIVED FROM MONOCYTES, AND METHOD FOR INDUCING THE DIFFERENTIATION THEREOF
|
|
CA2760574C
(en)
|
2009-05-01 |
2020-10-27 |
Cytori Therapeutics, Inc. |
Device and method for preparing tissue for an adipose graft
|
|
JP5856059B2
(ja)
|
2009-08-28 |
2016-02-09 |
ザ クリーブランド クリニック ファウンデーション |
虚血組織を治療するためのｓｄｆ−１送達
|
|
CA2776452A1
(en)
*
|
2009-10-02 |
2011-04-07 |
Baxter International Inc. |
Hematopoietic stem cells for use in the treatment of a kidney injury
|
|
ES2610241T3
(es)
|
2009-10-23 |
2017-04-26 |
Amorcyte, Inc. |
Composiciones y usos para el tratamiento de lesiones miocárdicas progresivas debidas a una insuficiencia vascular
|
|
WO2012019168A2
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
DE19177059T1
(de)
|
2010-10-01 |
2021-10-07 |
Modernatx, Inc. |
N1-methyl-pseudouracile enthältendes ribonucleinsäuren sowie ihre verwendungen
|
|
WO2012048276A2
(en)
|
2010-10-08 |
2012-04-12 |
Caridianbct, Inc. |
Customizable methods and systems of growing and harvesting cells in a hollow fiber bioreactor system
|
|
NZ609567A
(en)
*
|
2010-11-05 |
2015-05-29 |
Transbio Ltd |
Markers of endothelial progenitor cells and uses thereof
|
|
US9198975B2
(en)
|
2010-12-01 |
2015-12-01 |
The University Of North Carolina At Chapel Hill |
Methods and compositions for targeting sites of neovascular growth
|
|
DE12722942T1
(de)
|
2011-03-31 |
2021-09-30 |
Modernatx, Inc. |
Freisetzung und formulierung von manipulierten nukleinsäuren
|
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
|
JP6113737B2
(ja)
|
2011-10-03 |
2017-04-12 |
モデルナティエックス インコーポレイテッドＭｏｄｅｒｎａＴＸ，Ｉｎｃ． |
修飾型のヌクレオシド、ヌクレオチドおよび核酸、ならびにそれらの使用方法
|
|
US9533010B2
(en)
|
2011-10-31 |
2017-01-03 |
Amorcyte, Llc |
Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency
|
|
MX2014007233A
(es)
|
2011-12-16 |
2015-02-04 |
Moderna Therapeutics Inc |
Composiciones de nucleosidos, nucleotidos y acidos nucleicos modificados.
|
|
US20130216495A1
(en)
|
2012-02-21 |
2013-08-22 |
Baxter Healthcare Sa |
Pharmaceutical composition comprising cd34+ cells
|
|
EP2834259A4
(en)
|
2012-04-02 |
2016-08-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES
|
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
|
CA2892529C
(en)
|
2012-11-26 |
2023-04-25 |
Moderna Therapeutics, Inc. |
Terminally modified rna
|
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
|
CA2926218A1
(en)
|
2013-10-03 |
2015-04-09 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding low density lipoprotein receptor
|
|
WO2015073918A1
(en)
|
2013-11-16 |
2015-05-21 |
Terumo Bct, Inc. |
Expanding cells in a bioreactor
|
|
CN106232800B
(zh)
|
2014-03-25 |
2020-07-03 |
泰尔茂比司特公司 |
介质的被动替代
|
|
CN106715676A
(zh)
|
2014-09-26 |
2017-05-24 |
泰尔茂比司特公司 |
按计划供养
|
|
WO2017004592A1
(en)
|
2015-07-02 |
2017-01-05 |
Terumo Bct, Inc. |
Cell growth with mechanical stimuli
|
|
WO2017205667A1
(en)
|
2016-05-25 |
2017-11-30 |
Terumo Bct, Inc. |
Cell expansion
|
|
US11685883B2
(en)
|
2016-06-07 |
2023-06-27 |
Terumo Bct, Inc. |
Methods and systems for coating a cell growth surface
|
|
US11104874B2
(en)
|
2016-06-07 |
2021-08-31 |
Terumo Bct, Inc. |
Coating a bioreactor
|
|
CN110612344B
(zh)
|
2017-03-31 |
2023-09-12 |
泰尔茂比司特公司 |
细胞扩增
|
|
US11624046B2
(en)
|
2017-03-31 |
2023-04-11 |
Terumo Bct, Inc. |
Cell expansion
|
